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Objective
Compare the diagnostic performance of Cardiac Mag-
netic Resonance (CMR) myocardial perfusion imaging
against Positron Emission Tomography (PET) in coron-
ary artery disease (CAD).
Background
PET is regarded as the non-invasive reference-standard
for assessment of myocardial perfusion. However, there
are few data comparing the performance of CMR
against PET perfusion imaging, particularly in patients
with a high prevalence of CAD. In addition, novel MR
techniques, e.g. based on kt acceleration techniques,
allow perfusion imaging with improved spatial
resolution.
Methods
22 patients with known or suspected CAD underwent
both
13N-Ammonia PET and CMR adenosine stress and
rest perfusion imaging prior to diagnostic coronary X-
ray angiography (CXA). CMR perfusion imaging was
performed at 1.5T with a kt-accelerated steady-state
free-precession sequence.
Data analysis was blind. A significant coronary artery
stenosis was defined as at least 70% diameter reduction
or a fractional flow reserve <0.8. Sensitivity and specifi-
city for PET and CMR versus invasive angiography were
calculated. Localization of ischaemia was assessed in
patients with CAD by classifying territories that were
ischaemic on imaging as either supplied by, or as remote
from, a stenotic artery.
Results
Patient characteristics-table 1. 1 CMR examination was
non-diagnostic. The prevalence of CAD was 82%. Mean
interval ± standard deviation between PET and CMR scans
was 3±7 days (73% same day); between PET and CXA was
19±21 days and between CMR and CXA 20±23 days.
For the detection of CAD PET sensitivity was 83%
(95% CI 58-96%) and specificity 75% (95% CI 22-99%).
CMR sensitivity was 82% (95% CI 56-95%) and specifi-
city 75% (95% CI 22-99%). In the 18 patients with CAD
there was detectable ischaemia in 79% of the coronary
artery territories supplied by significantly stenotic
arteries with both PET and CMR. Ischaemia was also
detected in 20% of remote territories with PET and 17%
with CMR. 50% (n=3) of the territories with remote
ischaemia on PET imaging also had remote ischaemia
on CMR imaging.
Conclusions
Perfusion CMR imaging appears to be as good as PET
for the diagnosis of CAD. However the numbers are
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Table 1 Patient characteristics
Age (Mean±SD) 64±10 years
Male 77%
Diabetes 32%
Previous percutaneous coronary intervention 32%
Hypertension 59%
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further work is required. In patients with CAD localiza-
tion of ischaemia to a coronary territory is comparable
with both modalities. Using an anatomic test as the
reference-standard for functional tests has well-
described limitations. Remote ischaemia is likely to
occur for several reasons including underestimation of
disease severity at CXA, microvascular disease and also
false positive results.
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